China Pharma Holdings Inc is a company principally engaged in the development, manufacture and marketing of pharmaceutical products. The Company's products are for human use in connection, and with a variety of high-incidence and high-mortality diseases and medical conditions prevalent. The Company manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. In addition, the Company is also engaged in the production of comprehensive healthcare products and protective products.
Growing
The company is in a growing phase, with the latest annual income totaling USD 4.53M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 19.22.
Fairly Valued
The company’s latest PE is -0.67, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 721.01K shares, increasing 7.77% quarter-over-quarter.